The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Casiflux     calcium dioxido-oxo-silane

Synonyms: Florite, Fuwalip, Okenite, Rivaite, Vilnite, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of calcium dioxido-oxo-silane

 

High impact information on calcium dioxido-oxo-silane

 

Chemical compound and disease context of calcium dioxido-oxo-silane

 

Biological context of calcium dioxido-oxo-silane

  • The in vivo rat absorption study showed that Florite RE 10 mg preparation had the highest C(max) (2.14+/-0.67 microg/ml) and AUC (4.74+/-1.21 microg h/ml) [14].
  • The test in marrow indicated that wollastonite coatings could induce new bone formation on their surface showing good bone inductivity property [10].
  • The aim of the present study was to improve the solubility and oral bioavailability of a poorly water-soluble drug, 3-bis(4-methoxyphenyl) methylene-2-indolinone (TAS-301), by its melt-adsorption on a porous calcium silicate, Florite RE (FLR), without any solvents [15].
  • We conclude that there is inadequate evidence for the carcinogenicity of wollastonite in animals and, based on strong evidence that wollastonite is not biopersistent, believe that a well-designed animal inhalation bioassay would have a negative result [3].
  • A review of the toxicology and epidemiology of wollastonite [3].
 

Anatomical context of calcium dioxido-oxo-silane

  • Mechanism of apatite formation on wollastonite coatings in simulated body fluids [16].
  • Wollastonite fibers were also analyzed for their ability to lyse erythrocytes and activate complement [17].
  • Bonding behavior of a glass-ceramic containing apatite and wollastonite in segmental replacement of the rabbit tibia under load-bearing conditions [18].
  • Effects of apatite and wollastonite containing glass-ceramic powder and two types of alumina powder in composites on osteoblastic differentiation of bone marrow cells [19].
  • We examined the behavior of fetal rat chondrocytes cultured on a bioactive glass-ceramic containing apatite and wollastonite (A.W.G.C.). Biomaterial surface topography and profiles were evaluated by bidimensional profilometry and revealed a rough surface for the glass-ceramic compared to the plastic coverslips used as controls [20].
 

Associations of calcium dioxido-oxo-silane with other chemical compounds

  • Other preparations had C(max) and AUC of 0.69+/-0.10 microg/ml and 1.56+/-0.43 microg h/ml for Florite RE 20 mg, 1.07+/-0.31 microg/ml and 1.80+/-0.33 microg h/ml for Neusilin US2, and 0.99+/-0.21 microg/ml and 1.77+/-0.50 micorg h/ml for Sylysia 320, respectively [14].
  • The microporous calcium silicate preparation using Florite RE 10 mg was evaluated in dogs after oral administration in an enteric capsule, Eudragit S100 (50 mg/dog) [14].
  • Carbonate-containing hydroxyapatite (CHA) layer was formed on the surface of the wollastonite and W7T3 coatings soaked in simulated body fluid, while was not formed on the surface of the TiO2 and W3T7 coatings after immersion [21].
  • Preparation, characterization and in vitro release of gentamicin from PHBV/wollastonite composite microspheres [22].
  • The results showed a carbonate-containing hydroxyapatite layer formed on the surface of a plasma-sprayed wollastonite coating soaked in simulated body fluids, and a silica-rich layer appeared on the surface of the coating before the formation of the carbonate-containing hydroxyapatite layer [23].
 

Gene context of calcium dioxido-oxo-silane

  • Wollastonite decreased only the activity of gamma-glutamyl transpeptidase and glutathione peroxidase [2].
  • We investigated the differences between the lavage parameters -- including tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) release by lavage leukocytes -- in control rats and in animals intratracheally instilled with short and long amosite and wollastonite fibres [24].
  • Composites of PBT with wollastonite in two different proportions, viz [25].
  • The (29)Si MAS NMR spectra of rankinite and wollastonite clearly resolve manifolds of spinning sidebands from two and three Si sites, respectively, allowing the CSA parameters to be obtained with high precision for each site [26].
  • Meloxicam was adsorbed on the Florite RE (FLR) by fast evaporation of solvent from drug solution containing dispersed FLR [27].
 

Analytical, diagnostic and therapeutic context of calcium dioxido-oxo-silane

References

  1. Wollastonite exposure and lung fibrosis. Huuskonen, M.S., Tossavainen, A., Koskinen, H., Zitting, A., Korhonen, O., Nickels, J., Korhonen, K., Vaaranen, V. Environmental research. (1983) [Pubmed]
  2. Pulmonary toxicity of wollastonite in vivo and in vitro. Tátrai, E., Kováciková, Z., Brózik, M., Six, E. Journal of applied toxicology : JAT. (2004) [Pubmed]
  3. A review of the toxicology and epidemiology of wollastonite. Maxim, L.D., McConnell, E.E. Inhalation toxicology. (2005) [Pubmed]
  4. Ferromagnetic hyperthermia in rabbit eyes using a new glass-ceramic thermoseed. Matsumoto, M., Yoshimura, N., Honda, Y., Hiraoka, M., Ohura, K. Graefes Arch. Clin. Exp. Ophthalmol. (1994) [Pubmed]
  5. Enhanced viral interferon induction by the mineral wollastonite. Hahon, N., Booth, J.A., Boehlecke, B.A., Merchant, J.A. J. Interferon Res. (1980) [Pubmed]
  6. Effect of size of man-made and natural mineral fibers on chemiluminescent response in human monocyte-derived macrophages. Ohyama, M., Otake, T., Morinaga, K. Environ. Health Perspect. (2001) [Pubmed]
  7. Mesothelial cell apoptosis is confirmed in vivo by morphological change in cytokeratin distribution. Marchi, E., Liu, W., Broaddus, V.C. Am. J. Physiol. Lung Cell Mol. Physiol. (2000) [Pubmed]
  8. Asbestos and silica-induced changes in human alveolar macrophage phenotype. Holian, A., Uthman, M.O., Goltsova, T., Brown, S.D., Hamilton, R.F. Environ. Health Perspect. (1997) [Pubmed]
  9. Investigation of the biodurability of wollastonite and xonotlite. Bellmann, B., Muhle, H. Environ. Health Perspect. (1994) [Pubmed]
  10. In vivo evaluation of plasma-sprayed wollastonite coating. Xue, W., Liu, X., Zheng, X., Ding, C. Biomaterials (2005) [Pubmed]
  11. Red blood cell damage by wollastonite: in vitro study. Aslam, M., Arif, M.J., Rahman, O. Journal of applied toxicology : JAT. (1995) [Pubmed]
  12. Preliminary results from a cohort of workers exposed to wollastonite in a Finish limestone quarry. Huuskonen, M.S., Järvisalo, J., Koskinen, H., Nickels, J., Räsänen, J., Asp, S. Scandinavian journal of work, environment & health. (1983) [Pubmed]
  13. Osteoconduction of bioceramics in normal and osteopenic rats: comparison between bioactive and bioinert ceramics. Iwashita, Y., Yamamuro, T., Kasai, R., Kitsugi, T., Nakamura, T., Okumura, H., Kokubo, T. Journal of applied biomaterials : an official journal of the Society for Biomaterials. (1992) [Pubmed]
  14. Oral solid gentamicin preparation using emulsifier and adsorbent. Ito, Y., Kusawake, T., Ishida, M., Tawa, R., Shibata, N., Takada, K. Journal of controlled release : official journal of the Controlled Release Society. (2005) [Pubmed]
  15. Improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate. Kinoshita, M., Baba, K., Nagayasu, A., Yamabe, K., Shimooka, T., Takeichi, Y., Azuma, M., Houchi, H., Minakuchi, K. Journal of pharmaceutical sciences. (2002) [Pubmed]
  16. Mechanism of apatite formation on wollastonite coatings in simulated body fluids. Liu, X., Ding, C., Chu, P.K. Biomaterials (2004) [Pubmed]
  17. Wollastonite fibers in vitro generate reactive oxygen species able to lyse erythrocytes and activate the complement alternate pathway. Governa, M., Camilucci, L., Amati, M., Visonà, I., Valentino, M., Botta, G.C., Campopiano, A., Fanizza, C. Toxicol. Sci. (1998) [Pubmed]
  18. Bonding behavior of a glass-ceramic containing apatite and wollastonite in segmental replacement of the rabbit tibia under load-bearing conditions. Kitsugi, T., Yamamuro, T., Kokubo, T. The Journal of bone and joint surgery. American volume. (1989) [Pubmed]
  19. Effects of apatite and wollastonite containing glass-ceramic powder and two types of alumina powder in composites on osteoblastic differentiation of bone marrow cells. Nishio, K., Neo, M., Akiyama, H., Okada, Y., Kokubo, T., Nakamura, T. J. Biomed. Mater. Res. (2001) [Pubmed]
  20. Behavior of fetal rat chondrocytes cultured on a bioactive glass-ceramic. Loty, C., Forest, N., Boulekbache, H., Kokubo, T., Sautier, J.M. J. Biomed. Mater. Res. (1997) [Pubmed]
  21. Plasma sprayed wollastonite/TiO2 composite coatings on titanium alloys. Liu, X., Ding, C. Biomaterials (2002) [Pubmed]
  22. Preparation, characterization and in vitro release of gentamicin from PHBV/wollastonite composite microspheres. Li, H., Chang, J. Journal of controlled release : official journal of the Controlled Release Society. (2005) [Pubmed]
  23. Reactivity of plasma-sprayed wollastonite coating in simulated body fluid. Liu, X., Ding, C. J. Biomed. Mater. Res. (2002) [Pubmed]
  24. Some bronchoalveolar lavage parameters and leukocyte cytokine release in response to intratracheal instillation of short and long asbestos and wollastonite fibres in rats. Hurbánková, M., Kaiglová, A. Physiological research / Academia Scientiarum Bohemoslovaca. (1997) [Pubmed]
  25. Preparation, characterization and in vitro biocompatibility evaluation of poly(butylene terephthalate)/wollastonite composites. Risbud, M., Saheb, D.N., Jog, J., Bhonde, R. Biomaterials (2001) [Pubmed]
  26. 29Si chemical shift anisotropies in calcium silicates from high-field 29Si MAS NMR spectroscopy. Hansen, M.R., Jakobsen, H.J., Skibsted, J. Inorganic chemistry. (2003) [Pubmed]
  27. Low density multiparticulate system for pulsatile release of meloxicam. Sharma, S., Pawar, A. International journal of pharmaceutics. (2006) [Pubmed]
  28. Bioactive glass-ceramic containing crystalline apatite and wollastonite initiates biomineralization in bone cell cultures. Sautier, J.M., Kokubo, T., Ohtsuki, T., Nefussi, J.R., Boulekbache, H., Oboeuf, M., Loty, S., Loty, C., Forest, N. Calcif. Tissue Int. (1994) [Pubmed]
  29. A new model formulation of the SiO2-Al2O3-B2O3-MgO-CaO-Na2O-F glass-ceramics. Agathopoulos, S., Tulyaganov, D.U., Valério, P., Ferreira, J.M. Biomaterials (2005) [Pubmed]
 
WikiGenes - Universities